1AD.AX

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Biotechnology

Analyst estimates (consensus)

Year	Est. revenue	Growth	Est. EPS	EPS range	Fwd P/E	# Analysts
2027	$4M	+0.0%	$-0.04	$-0.04–$-0.04	—	1
2028	$2M	-51.8%	$-0.02	$-0.02–$-0.02	—	1
2029	$3M	+87.3%	$-0.02	$-0.02–$-0.02	—	1
2030	$3M	-2.3%	$-0.03	$-0.03–$-0.03	—	1

Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep

DCF fair valuemodel estimate

Intrinsic value

$0.00

Price

$0.00

Implied downside

-80%

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
1AD.AXAdAlta Limited	$0.00	+0.00%	$2M	—
ACR.AXAcrux Limited	$0.01	-9.09%	$6M	—
ANR.AXAnatara Lifesciences Ltd	$0.01	+0.00%	$2M	—
BIT.AXBiotron Limited	$0.00	+0.00%	$3M	—
CTQ.AXCareteq Limited	$0.01	-6.67%

AdAlta Limited

AdAlta Limited is an Australian-based clinical-stage biotechnology company dedicated to the discovery and development of innovative protein therapeutics. Its leading investigational i-body drug candidate, AD-214, is presently in Phase I clinical trials for the treatment of idiopathic pulmonary fibrosis (IPF) and other related fibrotic diseases. The company has forged strategic alliances, including a collaboration with GE Healthcare to identify i-bodies that bind to granzyme B, and a partnership with Carina Biotech Pty Ltd. focused on developing CAR-T cell products designed to target various solid tumor antigens. AdAlta Limited was founded in 2006 and is headquartered in Bundoora, Australia.

adalta.com.au

Employees: 2
IPO / List date: Aug 22, 2016
HQ: AU

Held by traders on TradeandTell

No one on the platform currently holds 1AD.AX.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in 1AD.AX as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded 1AD.AX yet.